Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Current Perspectives on Severe Drug Eruption
Jingzhan Zhang, Zixian Lei, Xu Chen, et al.
Clinical Reviews in Allergy & Immunology (2021) Vol. 61, Iss. 3, pp. 282-298
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Ninth Special Issue
Laura Connelly‐Smith, Caroline R. Alquist, Nicole A. Aqui, et al.
Journal of Clinical Apheresis (2023) Vol. 38, Iss. 2, pp. 77-278
Closed Access | Times Cited: 293
Oral Antibiotics and Risk of Serious Cutaneous Adverse Drug Reactions
Erika Yue Lee, Tara Gomes, Aaron M. Drucker, et al.
JAMA (2024) Vol. 332, Iss. 9, pp. 730-730
Closed Access | Times Cited: 13
Case report: Apalutamide-induced severe lethal cutaneous adverse effects in China
Qi Wang, Hua-Li Cao, Xuetong Zhang, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 9
Severe cutaneous adverse reactions to drugs: A real-world pharmacovigilance study using the FDA Adverse Event Reporting System database
Dongxuan Li, Jinghui Gou, Jun Zhu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 17
Inhibition of tumor necrosis factor improves conventional steroid therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis in a cohort of patients
Suiting Ao, Xuemei Gao, Jipang Zhan, et al.
Journal of the American Academy of Dermatology (2022) Vol. 86, Iss. 6, pp. 1236-1245
Closed Access | Times Cited: 25
Exosomal miRNAs in autoimmune skin diseases
Ri Zhang, Yujia Wei, Tingmei Wang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12
Pathological changes in various organs in HLA-B*57:01 transgenic mice with abacavir-induced skin eruption
Akira Kazaoka, Kazuyoshi Kumagai, Junya Matsushita, et al.
Toxicological Research (2024) Vol. 40, Iss. 2, pp. 223-235
Open Access | Times Cited: 4
Medication Associations With Severe Cutaneous Adverse Reactions: A Case/Non-Case Analysis Using the FDA Adverse Event Reporting System
Hannah Godfrey, Patrick Jedlowski, Rebecca Thiede
Journal of Cutaneous Medicine and Surgery (2024) Vol. 28, Iss. 1, pp. 51-58
Closed Access | Times Cited: 4
Severe cutaneous adverse reactions associated with the immune checkpoint inhibitors: A case/non‐case analysis using the Food and Drug Administration Adverse Event Reporting System
Hannah Godfrey, Patrick Jedlowski, Rebecca Thiede
Australasian Journal of Dermatology (2024) Vol. 65, Iss. 3, pp. 243-253
Closed Access | Times Cited: 4
Latin American guidelines for the diagnosis and treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis
Andrea Dionelly Murillo-Casas, Ricardo Zwiener, Pedro Giavina‐Bianchi, et al.
World Allergy Organization Journal (2025) Vol. 18, Iss. 4, pp. 101046-101046
Open Access
Immune-checkpoint Inhibitors in Anti-cancer Armamentarium: a Double-edged Sword in Risk of Developing Autoimmunity and Immune-related Adverse Effects

Frontiers research topics (2025)
Closed Access
Systematic review: characteristics of myocarditis followed by fixed drug eruption and dry eye syndrome in patients who have been vaccinated with monkeypox in children and adults
R. Mohamad Javier, Stephanie Angela Prijanto, Vallexa Septina Yora, et al.
Frontiers in Cardiovascular Medicine (2025) Vol. 11
Open Access
Impact of non-genetic factors on severe cutaneous adverse reactions and associated mortality in ESRD patients: Advancing clinical guidance
Katlyn M Smaha, Nadia N Talebi, Jennifer L. Waller, et al.
The American Journal of the Medical Sciences (2025)
Closed Access
Toxic Epidermal Necrolysis in a Boy with Dravet Syndrome: Clinical Case
Aset Kh. Ibisheva, Lechi R. Kagaev, Linda V.-M. Dzhabrailova, et al.
Педиатрическая фармакология (2025) Vol. 22, Iss. 1, pp. 12-18
Open Access
Targeted therapy for immune mediated skin diseases. What should a dermatologist know?
Edinson López, Raúl Cabrera, Cristóbal Lecaros
Anais Brasileiros de Dermatologia (2024) Vol. 99, Iss. 4, pp. 546-567
Open Access | Times Cited: 3
DNA methylation of ITGB2 contributes to allopurinol hypersensitivity
Yu Liu, Chuang‐Wei Wang, Chun‐Bing Chen, et al.
Clinical Immunology (2023) Vol. 248, pp. 109250-109250
Closed Access | Times Cited: 8
Causes and Management of Cutaneous Adverse Drug Reactions: A Comprehensive Review
Arsh Sutaria, Shobha Rawlani, Amita Sutaria
Cureus (2024)
Open Access | Times Cited: 2
Toxic epidermal necrosis associated with afatinib: A case report and literature review
Wei Yang, Yansong Lu, Ze Wu, et al.
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 5
Causes of Drug-Induced Severe Cutaneous Adverse Reaction Epidermal Necrolysis (EN): An Analysis Using FDA Adverse Event Reporting System (FAERS) Database
Weiqiang Fei, Jun Shen, Hui Cai
Clinical Cosmetic and Investigational Dermatology (2023) Vol. Volume 16, pp. 2249-2257
Open Access | Times Cited: 5
Optimal Practices in the Delivery of Aesthetic Medical Care to Patients on Immunosuppressants and Immunomodulators: A Systematic Review of the Literature
Leila Cattelan, Steven Dayan, Sabrina G. Fabi
Aesthetic Surgery Journal (2024) Vol. 44, Iss. 11, pp. NP819-NP828
Closed Access | Times Cited: 1
Clinical observation and analysis of rash caused by lacosamide in children with epilepsy
Yingying Guo, Yu Liu, Dan Li, et al.
Seizure (2024) Vol. 117, pp. 105-110
Open Access | Times Cited: 1
TNF-α inhibitors as therapy for drug-induced severe cutaneous adverse reactions: a case series
Yanjun Chu, Mengjun Xu, Xiaoqing Dong, et al.
Journal of Dermatological Treatment (2024) Vol. 35, Iss. 1
Open Access | Times Cited: 1
Oral cyclosporine treatment for four pediatric patients with toxic epidermal necrolysis that showed no response to high-dose corticosteroids in combination with intravenous immunoglobulin: A Case series
Peijing Li, Qin Yao, Yuanyuan Wang, et al.
Current Therapeutic Research (2024) Vol. 102, pp. 100767-100767
Open Access | Times Cited: 1
Development of a Skin-Directed Scoring System for Stevens-Johnson Syndrome and Epidermal Necrolysis
Margo Waters, Allison S. Dobry, Stephanie T. Le, et al.
JAMA Dermatology (2023) Vol. 159, Iss. 7, pp. 772-772
Open Access | Times Cited: 3
Etanercept leads to a rapid recovery of a Dabrafenib‐/Trametinib‐associated toxic epidermal necrolysis‐like severe skin reaction
Krista Yordanova, Claudia Pföhler, Luca Filomena Schweitzer, et al.
Skin Health and Disease (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top